NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
On Target Laboratories, LLC
George Washington University
Novartis
Vanderbilt-Ingram Cancer Center
Tongji Hospital
Groupe Francais De Pneumo-Cancerologie
AstraZeneca
Novartis
Korea University Guro Hospital